Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-07-10Clinical Trial Update: Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers [Phase 1]
Phase I clinical trial updates indicate completion of a safety, tolerability, and pharmacokinetics evaluation of YHB1411-2 in healthy male v…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions
Completed clinical trial evaluating the safety and efficacy of Mobic Ampoules (meloxicam) for initiating treatment of painful flare-ups in o…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases
A completed observational study evaluated the use of meloxicam in Mexican patients with rheumatoid arthritis and other rheumatic diseases.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome
An observational cohort study comparing the safety and efficacy of meloxicam versus other NSAIDs has completed in patients with rheumatoid a…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs. [Phase 4]
Phase 4 study evaluating adding tocilizumab to DMARDs in patients with moderate to severe rheumatoid arthritis not adequately controlled by …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies [Phase 2]
Open-label extension study for rheumatoid arthritis patients completing a Phase 2 trial of R935788; the study was terminated and results wer…
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled study in active rheumatoid arthritis including an MRI sub-study was terminated, with …
-
CLINICAL_TRIALS research · 2014-06-25Clinical Trial Update: Study Evaluating the Efficacy of Thick Shell Mussel Lipid Extract in Chinese Subjects With Rheumatoid Arthritis [NA]
This entry notes a clinical trial in Chinese subjects with rheumatoid arthritis evaluating the efficacy of thick shell mussel lipid extract.…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate [Phase 1]
A Phase 1 dose-escalation study evaluating safety, tolerability, and pharmacokinetics of a single intravenous dose of ASP2409 in patients wi…
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy [NA]
This document summarizes the results of a completed clinical trial evaluating the effect of rituximab therapy on cardiovascular risk markers…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel) [Phase 4]
This document reports the completion of a Phase 4 clinical trial evaluating etanercept (Enbrel) for moderate rheumatoid arthritis, with resu…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: CAMEO: Canadian Methotrexate and Etanercept Outcome Study [Phase 4]
Phase 4 Canadian trial (CAMEO) evaluating methotrexate in combination with etanercept for rheumatoid arthritis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety [Phase 2]
Phase 2 study in rheumatoid arthritis comparing two formulations of adalimumab to evaluate pharmacokinetics, pharmacodynamics, and safety. T…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis. [Phase 3]
Phase 3 clinical trial update evaluating tocilizumab in adults with active rheumatoid arthritis reports on efficacy and safety outcomes. The…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate [Phase 4]
A Phase 4 study evaluating Rituximab (MabThera) in rheumatoid arthritis patients with inadequate response to methotrexate; results were post…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
A completed clinical trial update investigating biomarkers to predict nonresponse to anti-TNF-α therapy in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs [Phase 3]
Phase 3 clinical trial evaluating tocilizumab in combination with methotrexate for active rheumatoid arthritis in patients who had an inadeq…
-
FDA approval · 2014-05-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited under BLA125057.
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 2]
Phase 2 safety and effectiveness study of RWJ-445380, a Cathepsin-S inhibitor, in patients with active rheumatoid arthritis despite methotre…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA [Phase 2]
Phase 2 trial evaluating CRx-102 added to DMARD therapy versus placebo added to DMARD therapy in rheumatoid arthritis; results have been pos…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: TIV and High Dose TIV in Subjects With Rheumatoid Arthritis [Phase 2]
Phase 2 trial comparing standard trivalent influenza vaccine (TIV) and high-dose TIV in subjects with rheumatoid arthritis to evaluate safet…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Observational Trial With Enbrel
Pfizer-sponsored observational study of Enbrel (etanercept) in rheumatoid arthritis has completed and posted results in May 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) [Phase 3]
Phase 3 trial evaluating golimumab in rheumatoid arthritis patients with inadequate response to etanercept or adalimumab; results have been …
-
CLINICAL_TRIALS research · 2014-05-13Clinical Trial Update: Primary TKA Cruciate Retaining vs Cruciate Substituting With Rotating Platform Knee Prostheses [NA]
This clinical trial update describes a study comparing primary total knee arthroplasty using cruciate-retaining versus cruciate-substituting…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients [Phase 2]
This clinical trial update describes a Phase 2 study evaluating two doses of MRC375 in adults with moderate to severe rheumatoid arthritis. …